Join the AHA as Dr. Robert Mentz and Dr. Stephen Greene provide clinical overviews of how intravenous iron and potassium binders can be effectively integrated into heart failure management. These experts will review the prevalence of iron deficiency and hyperkalemia in heart failure, discuss current evidence-based treatment recommendations, and share strategies for real-world implementation to improve patient symptoms, optimize guideline-directed medical therapy, and enhance patient outcomes.

Register Here